EFG International’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.35M Buy
14,840
+2,360
+19% +$319K 0.04% 321
2026
Q1
$1.59M Buy
12,480
+100
+0.8% +$12.5K 0.03% 356
2025
Q4
$1.51M Buy
+12,380
New +$1.42M 0.03% 341

Other funds holding XBI

EFG International's XBI Position: Q2 2026 in Review

EFG International increased its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q2 2026, buying an estimated $319K and bringing the position to 14,840 shares worth $2.35M. The position accounts for 0.04% of the portfolio, ranked #321.

EFG International first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • EFG International held 14,840 shares of State Street SPDR S&P Biotech ETF worth $2.35M as of Q2 2026.
  • EFG International bought 2,360 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $319K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of EFG International's portfolio in Q2 2026, its #321 holding.
  • EFG International first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.